These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30638028)

  • 1. The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.
    McKinnon LR; Achilles SL; Bradshaw CS; Burgener A; Crucitti T; Fredricks DN; Jaspan HB; Kaul R; Kaushic C; Klatt N; Kwon DS; Marrazzo JM; Masson L; McClelland RS; Ravel J; van de Wijgert JHHM; Vodstrcil LA; Tachedjian G
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):219-228. PubMed ID: 30638028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
    Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
    Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
    J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial vaginosis and the cervicovaginal immune response.
    Mitchell C; Marrazzo J
    Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
    Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
    J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Women and Their Male Sex Partners Predict Bacterial Vaginosis Among a Prospective Cohort of Kenyan Women With Nonoptimal Vaginal Microbiota.
    Mehta SD; Agingu W; Nordgren RK; Green SJ; Bhaumik DK; Bailey RC; Otieno F
    Sex Transm Dis; 2020 Dec; 47(12):840-850. PubMed ID: 32773610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
    Masson L; Barnabas S; Deese J; Lennard K; Dabee S; Gamieldien H; Jaumdally SZ; Williamson AL; Little F; Van Damme L; Ahmed K; Crucitti T; Abdellati S; Bekker LG; Gray G; Dietrich J; Jaspan H; Passmore JS
    Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
    Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
    Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.
    Cheu RK; Gustin AT; Lee C; Schifanella L; Miller CJ; Ha A; Kim C; Rodriguez VJ; Fischl M; Burgener AD; Arnold KB; Alcaide ML; Klatt NR
    PLoS Pathog; 2020 Dec; 16(12):e1009024. PubMed ID: 33270801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing of the vaginal microbiota of women with HIV.
    Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
    PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible?
    Shipitsyna E; Roos A; Datcu R; Hallén A; Fredlund H; Jensen JS; Engstrand L; Unemo M
    PLoS One; 2013; 8(4):e60670. PubMed ID: 23585843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis.
    Spear GT; Sikaroodi M; Zariffard MR; Landay AL; French AL; Gillevet PM
    J Infect Dis; 2008 Oct; 198(8):1131-40. PubMed ID: 18717638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.
    Murphy K; Mitchell CM
    J Infect Dis; 2016 Aug; 214 Suppl 1(Suppl 1):S29-35. PubMed ID: 27056955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the Art for Diagnosis of Bacterial Vaginosis.
    Muzny CA; Cerca N; Elnaggar JH; Taylor CM; Sobel JD; Van Der Pol B
    J Clin Microbiol; 2023 Aug; 61(8):e0083722. PubMed ID: 37199636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis.
    Zozaya M; Ferris MJ; Siren JD; Lillis R; Myers L; Nsuami MJ; Eren AM; Brown J; Taylor CM; Martin DH
    Microbiome; 2016 Apr; 4():16. PubMed ID: 27090518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.